DiaMedica Therapeutics Inc. Form SCHEDULE 13G: Beneficial ownership report (passive)
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-02-17: Form SCHEDULE 13G/A; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X01/primary_doc.xml.
- 2026-02-17: Form SCHEDULE 13G/A; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X01/primary_doc.xml.
- 2026-02-06: Form SCHEDULE 13G/A; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X01/primary_doc.xml.
- 2025-11-07: Form SCHEDULE 13G/A; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X01/primary_doc.xml.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-02-17 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml | |
| 2026-02-17 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml | |
| 2026-02-06 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml | |
| 2025-11-07 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml | |
| 2025-10-15 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml | |
| 2025-09-04 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml | |
| 2025-08-27 | SCHEDULE 13G | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml | |
| 2025-07-30 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml | |
| 2025-07-30 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X01/primary_doc.xml |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |